HIPRA has received the "Production and Manufacturing" award from Fundamed (Fundación de Ciencias del Medicamento y Productos Sanitarios) and the communication group specialised in health Wecare-U, for being a reference company committed to global health and for its contribution to the development of the territory thanks to its production and manufacturing centers, from where HIPRA's vaccines for animal and human health are produced to prevent diseases all over the world.

The person in charge of collecting the award on behalf of HIPRA was the Director of Vaccines, Toni Lloret, who acknowledged that this recognition would not have been possible without the talent of the HIPRA team: "We overcome challenges thanks to having a committed and tireless team, which always seeks excellence and works with an inexhaustible passion day after day. Together we have shown that, even in the most challenging times, we can achieve greatness by working with the same purpose: improving global health”. In this sense, he referred to such important milestones as "the development of a vaccine against COVID-19, which has become the first vaccine for human health developed in Spain, or being selected as one of the strategic partners for the EU-FAB project of the European Commission, reserving part of our production capacity for the possible production of recombinant protein vaccines in the event of future pandemics". 

With this award, HIPRA reaffirms its commitment to continue investing in research and technology, to continue investing in talent, to continue promoting agreements with public and private research centers and to continue carrying out sustainable practices that allow it to exceed the expectations of patients, clients and the medical community. 

Fundamed and Wecare-U recognize every year entities, pharmaceutical companies, institutions and personalities that have stood out in the last year. In addition, they promote initiatives around research and innovation, patient associations and their participation, as well as sustainability.